Clinical Trials in Minneapolis

Showing 9901-9920 of 14,456 trials

Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery

NCT02512861

All pediatric patients who undergo cardiac surgery require analgesic medications for postoperative pain control and many require sedation to facilitate comfort with cares. Parasternal infiltration of local anesthetic for nerve blocks is a simple option to postoperative analgesia. The investigators hypothesize that Bupivacaine, a parasternal nerve block administered in pediatric patients undergoing cardiac surgery will reduce the requirement of Opioids and other pain medications as well as decrease postoperative pain scores. This is a prospective, double-blind, randomized controlled trial. Subjects are randomized to receive either 0.25% Bupivacaine or normal saline following their cardiothoracic surgery.

Pain

Children's Hospitals and Clinics of Minnesota93 participantsStarted Apr 2014

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

NCT00699660

This project evaluated the impact of semi-structured, standardized interviews on the initial PTSD C\&P on the examination.

Post-Traumatic Stress Disorder

VA Office of Research and Development406 participantsStarted May 2009

North Little Rock, Arkansas, United States • Palo Alto, California, United States • West Haven, Connecticut, United States +8 more locations

Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

Find Trials by Condition in Minneapolis

Predicting Acute Compartment Syndrome (PACS)

EndovascuLar RegIstry Evaluating SafeTy, Efficacy and Patient Comfort (ELITE)

Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications: A Randomized Controlled Trial

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Transfusion Requirements in Cardiac Surgery III

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Automated Screen for Fetal Aneuploidy